AVITA Medical(RCEL) - 2024 Q3 - Quarterly Results

Exhibit 99.1 AVITA Medical Reports Third Quarter Financial Results VALENCIA, Calif., November 7, 2024 — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the third quarter ended September 30, 2024. Financial Results and Recent Business Updates • Commercial revenue of $19.5 million, an increase of approximately 44% compared to the same period in 2 ...